Charles River Laboratories | CRL - Дебиторская задолженность





Дебиторская задолженность Изменить Дата
Agilent USD 1.48B 20M 2026-06
Align Technology USD 1.15B 23.28M 2026-06
Bio-Rad Laboratories USD 441.8M 15.6M 2026-06
Bruker USD 545.9M 3.2M 2026-06
Cardinal Health USD 13.82B 167M 2026-06
Charles River Laboratories USD 711.76M 11.5M 2026-06
Cigna USD 30.8B 4.19B 2026-06
Concord Medical Services Hldg CNY 44.05M 13.31M 2025-12
CVS Health USD 40.31B 683M 2026-06
Danaher USD 4.96B 205M 2026-06
Dentsply International USD 620M 2M 2026-06
Elevance Health USD 23.39B 602M 2026-06
Humana USD 5.7B 477M 2026-06
Illumina USD 764M 26M 2026-06
Incyte USD 1.13B 73.7M 2026-06
Intrexon USD 1.02M 559K 2024-06
IQVIA Holdings USD 3.39B 12M 2026-06
Laboratory Of America USD 2.5B 54.3M 2026-06
Lakefront Biotherapeutics EUR 149.47M 95.44M 2026-06
Lonza CHF 1.78B 55M 2025-12
McKesson USD 30.32B 2.33B 2026-06
Merck EUR 4.95B 139M 2026-06
Mettler Toledo International USD 731.48M 23.27M 2026-06
Novartis USD 9.85B 252M 2026-06
Pfizer USD 16.19B 19M 2026-06
Quest Diagnostics USD 1.67B 79M 2026-06
Revvity USD 709.18M 17.79M 2026-06
Thermo Fisher Scientific USD 9.45B 247M 2026-06
United Therapeutics USD 310.3M 1.7M 2026-06
UnitedHealth USD 21.57B 5.01B 2026-06
Veradigm USD 175.72M 58.76M 2022-12
Waters USD 1.99B 228M 2026-06
West Pharmaceutical Services USD 712M 26.4M 2026-06